Presentation to highlight the approaches used in developing consistent cell-based potency assays meeting regulatory expectations (USP <1032> and <1033>) and are suitable for CGMP stability testing

Session to provide best practices, insights, and sample case studies for extractables and leachables studies in accordance with guidelines for the bio/pharmaceutical industry.